Search - tctmd.com

Displaying 401 - 420 of 1186

Sort: Relevancy | Date

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

News Daily News

Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study

Michael O'Riordan

November 18, 2022

Age-Related Macular Degeneration Linked to Severe Vascular Disease

News Daily News

Age-Related Macular Degeneration Linked to Severe Vascular Disease

November 18, 2022

AHA Statement Stresses Importance of Telehealth in CVD Care

News Daily News

AHA Statement Stresses Importance of Telehealth in CVD Care

Yael L. Maxwell

November 16, 2022

Many STEMI Patients Not Treated Within National Time Goals

News Daily News

Many STEMI Patients Not Treated Within National Time Goals

Michael O'Riordan

November 15, 2022

Sizeable Minority of Pregnant Women Have CVD, US Data Show

News Conference News AHA 2022

Sizeable Minority of Pregnant Women Have CVD, US Data Show

November 11, 2022

China Rural Intervention Still Reaping BP Control Wins at 3 Years

News Conference News AHA 2022

China Rural Intervention Still Reaping BP Control Wins at 3 Years

November 09, 2022

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

News Conference News AHA 2022

EMPA-KIDNEY: Empagliflozin a ‘Win’ for Patients With CKD

November 06, 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

News Conference News AHA 2022

In High BP, Chlorthalidone and Hydrochlorothiazide Have Similar Impact on MACE

November 05, 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

TCTMD’s Top 10 Most Popular Stories for October 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2022

October 31, 2022

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

News Daily News

More Endpoints, More Problems: FDA Offers Advice for Multi-endpoint Trials

Michael O'Riordan

October 28, 2022

Study Affirms Higher CVD, Mortality Risks Among COVID-Positive Patients

News Daily News

Study Affirms Higher CVD, Mortality Risks Among COVID-Positive Patients

October 26, 2022

Smartphone in Your Pocket Predicts 5-Year Risk of Dying

News Daily News

Smartphone in Your Pocket Predicts 5-Year Risk of Dying

Michael O'Riordan

October 21, 2022

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

News Daily News

COVID Drug Paxlovid Interacts With Widely Used CV Meds: Review

October 12, 2022

CV Risk Factors or Preexisting CVD: What’s Worse for COVID-19?

News Daily News

CV Risk Factors or Preexisting CVD: What’s Worse for COVID-19?

October 11, 2022

Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks

News Daily News

Big Tobacco Bets on Menthol to Hook Youth, Women, and Blacks

Michael O'Riordan

October 07, 2022

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

News Daily News

Sky-high Cost of SGLT2i and GLP1 Agonists Deter First-line Use

October 05, 2022

Food Insecurity Rose Over the Past 20 Years in Patients With CVD

News Daily News

Food Insecurity Rose Over the Past 20 Years in Patients With CVD

Yael L. Maxwell

September 29, 2022

Most Patient-Reported Outcome Measures in CVD Fall Short

News Daily News

Most Patient-Reported Outcome Measures in CVD Fall Short

September 23, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.